Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas.
Human Genetics Center, The University of Texas School of Public Health, Houston, Texas.
J Am Coll Cardiol. 2018 Jul 10;72(2):156-169. doi: 10.1016/j.jacc.2018.04.050.
Hypertriglyceridemia is associated with increased remnant-like particle cholesterol (RLP-C) and triglycerides in low-density lipoprotein (LDL-TG). Recent studies have focused on atherogenicity of RLP-C, with few data on LDL-TG.
The aim of this study was to examine associations of RLP-C and LDL-TG with incident cardiovascular disease (CVD) events and genetic variants in the ARIC (Atherosclerosis Risk In Communities) study.
Fasting plasma RLP-C and LDL-TG levels were measured in 9,334 men and women without prevalent CVD. Participants were followed for incident CVD events (coronary heart disease and ischemic stroke) for up to 16 years. Associations between LDL-TG and RLP-C levels and genetic variants were assessed by whole-exome sequencing using single-variant analysis for common variants and gene-based burden tests for rare variants; both an unbiased and a candidate gene approach were explored.
RLP-C and LDL-TG levels were correlated with triglyceride levels (r = 0.85 and r = 0.64, p < 0.0001). In minimally adjusted analyses, RLP-C and LDL-TG were associated with CVD risk, but in models adjusted for traditional risk factors including lipids, only LDL-TG was associated with incident CHD (hazard ratio: 1.28; 95% confidence interval: 1.10 to 1.50) and stroke (hazard ratio: 1.47; 95% confidence interval: 1.13 to 1.92). A common APOE variant, rs7412, had the strongest association with LDL-TG and RLP-C (p < 5 × 10).
RLP-C and LDL-TG levels were predictive of CVD and associated with APOE variants. LDL-TG may represent a marker of dysfunctional remnant lipoprotein metabolism associated with increased CVD risk. Further research is needed to determine whether LDL-TG plays a causal role in CVD and may be a target for therapy.
高甘油三酯血症与低密度脂蛋白(LDL)中的残余样颗粒胆固醇(RLP-C)和甘油三酯升高有关。最近的研究集中在 RLP-C 的致动脉粥样硬化性,关于 LDL-TG 的数据较少。
本研究旨在检查 ARIC(社区动脉粥样硬化风险)研究中 RLP-C 和 LDL-TG 与心血管疾病(CVD)事件的发生以及遗传变异的相关性。
在没有明确 CVD 病史的 9334 名男性和女性中测量空腹血浆 RLP-C 和 LDL-TG 水平。参与者的 CVD 事件(冠心病和缺血性中风)风险随访长达 16 年。通过全外显子组测序,采用单变量分析常见变异和基于基因的罕见变异负荷试验评估 LDL-TG 和 RLP-C 水平与遗传变异的相关性;探索了无偏倚和候选基因方法。
RLP-C 和 LDL-TG 水平与甘油三酯水平相关(r=0.85 和 r=0.64,p<0.0001)。在最小调整分析中,RLP-C 和 LDL-TG 与 CVD 风险相关,但在调整包括脂质在内的传统危险因素的模型中,只有 LDL-TG 与 CHD 发病相关(危险比:1.28;95%置信区间:1.10 至 1.50)和中风(危险比:1.47;95%置信区间:1.13 至 1.92)。APOE 变异体 rs7412 与 LDL-TG 和 RLP-C 的相关性最强(p<5×10)。
RLP-C 和 LDL-TG 水平可预测 CVD 并与 APOE 变异体相关。LDL-TG 可能代表与 CVD 风险增加相关的功能失调残余脂蛋白代谢的标志物。需要进一步研究以确定 LDL-TG 是否在 CVD 中起因果作用,并可能成为治疗的靶点。